Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection

Clinical and Experimental Rheumatology

Volumn 21, Issue 6 SUPPL. 32, 2003, Pages

  Lamprecht, Peter ^a,e   Gutzeit, Oliver ^a,e   Csernok, Elena ^a,e   Gause, Angela ^a,e   Longombardo, Giovanni ^b   Zignego, Anna Linda ^c   Gross, Wolfgang L ^a,e   Ferri, Clodoveo ^d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

ANCA; BPI ANCA; CG ANCA; Chronic hepatitis; HCV; Mixed cryoglobulinemia; Vasculitis

Indexed keywords

ANTIGEN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CATHEPSIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOPSY TECHNIQUE; BLOOD ANALYSIS; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CRYOGLOBULINEMIA; CYTOPLASM; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN TARGETING; SENSITIVITY ANALYSIS; VASCULITIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY; CRYOGLOBULINEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS C, CHRONIC; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; VASCULITIS;

EID: 0346882797     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. CHOO QL, KUO G, WEINER AJ, OVERBY LR, BRADLEY DW, HOUGHTON M: Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. FERRI C, GRECO F, LONGOMBARDO G et al.: Antibodies to hepatits C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606-10.
3. FERRI C, La CIVITA L, LONGOMBARDO G, GRECO F, BOMBARDIERI S: Hepatitic C virus and mixed cryoglobulinemia. Eur J Clin Invest 1993: 23: 399-405.
4. AGNELLO V, CHUNG RT, KAPLAN LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-95.
5. MISIANI R, BELLAVITA P, FENILI D et al.: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7.
6. ZIGNEGO AL, FERRI C, GIANNINI C et al.: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
7. CACOUB P, POYNARD T, GHILLANI P et al.: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 2204-12.
8. FERRI C, LACIVITA L, LONGOMBARDO G, ZIGNEGO AL, PASERO G: Mixed cryoglobulinemia: A cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998 7: 275-9.
9. MCMURRAY RW, ELBOURNE K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997: 26: 689-701.
10. McMURRAY RW: Hepatitis associated autoimmune disorders. Rheum Dis Clin North Am 1998: 24: 353-74.
11. AGNELLO V, ZHANG QX, ABEL G, KNIGHT GB: The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13 (Suppl. 13): S101-S104.
12. SINICO RA, FORNASIERI A, INDACO A et al.: Cross-reactive idiotypes on cryopreciptating monoclonal IgMk rheumatoid factors. Clin Exp Rheumatol 1995; 13 (Suppl. 13): S105-S107.
13. WARNY M, BRENARD R, CORNU C, TOMASI JP, GEUBEL AP: Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interfer-on therapy. J Hepatol 1993; 17: 294-300.
14. CACOUB P, NOEL LH, MUSSET L. LUNEL F, OPOLON P, PIETTE JC: Anti-neutrophil cytoplasmic antibodies and mixed cryoglobulinemia. Clin Exp Rheumatol 1994; 12: 693.
15. MALNICK SDH, BASS DD, STHOEGER ZM: C-ANCA as a marker of Wegener's disease. Lancet 1996; 347: 117-8.
16. LAMPRECHT P, SCHMITT WH, GROSS WL: Mixed cryoglobulinemia, glomerulonephritis, and ANCA: Essential cyroglobulinemic vasculitis or ANCA-associated vasculitis? Nephrol Dial Transplant 1998; 13: 213-21.
17. PAPI M, DIDONA B, GANTCHEVA M, CHINNI LM: Chronic hepatitis C virus infection, mixed cryoglobulinemia, leukocytoclastic vasculitis and antineutrophil cytoplasmic antibodies. Lupus 1997: 6: 737-8.
18. LAMPRECHT P, SCHNABEL A. CSERNOK E, GROSS WL: ANCA, anti-alpha-enolase anti-bodies and cryoglobulinemic vasculitis: pathogenetic implications. Clin Exp Rheumatol 1998; 16: 513
19. MONTI G, GALLI M. INVERNIZZI F et al.: Cryoglobulinaemias: A multi-centre study on the early clinical and laboratory manifestations of primary and secondary disease. Q J Med 1995; 88: 115-26.
20. FERRI C, ZIGNEGO AL, PILERI SA: Cryoglobulins. J Clin Pathol 2002; 55: 4-13.
21. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an international conference. Arthritis Rheum 1994; 37: 187-92.
22. HARTMANN H, SCHOTT P, POLZIEN F et al.: Cryoglobulinemia in chronic hepatitis C infection: Prevalence, clinical manifestations, response to interferon treatment and analysis of cryopreciptates. Z Gastroenterol 1995; 33: 643-50.
23. DE GROOT K, GROSS WL, HERLYN K, REINHOLD-KELLER E: Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001: 55: 31-38.
24. LUQMANI RA: Assessing disease activity in systemic vasculitides. Curr Opin Rheumatol 2002; 14: 23-8.
25. BROUET JC, CLAUVEL JP, DANON F, KLEIN M, SELIGMANN M: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57: 775-88.
26. HAGEN EC, DAHA MR, HERMANS J et al.: Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53: 743-53.
27. SCHNABEL A, CSERNOK E, ISENBERG DA, MROWKA C, GROSS WL: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 633-7.
28. SCHONERMARK U, LAMPRECHT P, CSERNOK E, GROSS WL: Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology 2001; 40: 178-84.
29. STOFFEL MP, CSERNOK E, HERZBERG C, JOHNSTON T, CAROLL SF, GROSS WL: Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability-increasing protein: A new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996; 104: 54-9.
30. LAMPRECHT P, MOOSIG F, GAUSE A, HERLYN K, GROSS WL: Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis. Clin Exp Rheumatol 2000; 18: 319-25.
31. CHOI HK, LAMPRECHT P, NILES JL, GROSS WL, MERKEL PA: Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000; 43: 226-31.
32. SOBAJIMA J. OZAKI S, OSAKADA F et al.: Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: Anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996; 105: 120-4.
33. ZHAO MH, JAYNE DR, ARDILES LG, CULLEY F, HODSON ME, LOCKWOOD CM: Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. Q J Med 1996; 89: 259-65.
34. SCHULTZ H, CSERNOK E, NIKKARI S, TOIVANEN P, TOIVANEN A, GROSS WL: BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognize exclusively the C-terminal part of the BPI molecule. Scand J Rheumatol 2000; 29: 226-31.
35. D'AMICO G: Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54: 650-71.
36. FERRI C, LA CIVITA L, CIRAFISI C et al.: Peripheral neuropathy in mixed cryoglobulinemia: Clinical and electrophysiologic investigations. J Rheumatol 1992; 19: 889-95.
37. DELLA ROSSA A, TAVONI A, BALDINI C, BOMBARDIERI S: Treatment of chronic hepatitis C infection with cryoglobulinemia. Curr Opin Rheumatol 2002; 13: 231-7.
38. ZIGNEGO AL. FERRI C, GIANNINI C et al.: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
39. LAMPRECHT P, MOOSIG F, GAUSE A et al.: Immunological and clinical follow up of hepatitis C virus associated cryoglobulinemic vasculitis. Ann Rheum Dis 2001; 60: 385-90.
40. AGNELLO V: Mixed cryoglobulinemia after hepatitis C virus: More or less ambiguity. Ann Rheum Dis 1998; 57: 701-2.
41. DAMMACCO F, SANSONNO D: Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 1997; 15: 97-119.